OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
GWAY.CD57

Greenway Greenhouse Cannabis Corp

Healthcare Facilities & ServicesVerified

Greenway Greenhouse Cannabis Corp has a debt-to-equity ratio of 1.57, indicating a moderate reliance on debt financing, and a current ratio of 0.49, suggesting potential liquidity constraints in the short term. The company's free cash flow is negative at -320,350 CAD, and its operating cash flow is 1,806,460 CAD, highlighting a mismatch between cash inflows and outflows. The return on equity is -20.47%, and the return on assets is -6.38%, both significantly below the industry median for profitability metrics. The company's operating income is -958,940 CAD, and its net income is -2,057,450 CAD, indicating a loss-making position. These figures are well below the industry median for operating and net margins, suggesting that Greenway Greenhouse Cannabis Corp is underperforming in terms of profitability. The company's capital expenditure of -194,370 CAD reflects ongoing investment in its operations, but the negative net income raises concerns about the sustainability of these investments. Greenway Greenhouse Cannabis Corp operates in three segments: Greenway Nursery, Greenway Cultivation, and Greenway Farmgate Retail Store. The company's revenue is concentrated in these segments, with no disclosed geographic diversification. The lack of geographic diversification increases the company's exposure to regional market risks. The company's revenue concentration in a single country (Canada) and within a narrow set of segments suggests a high level of business risk. The company's revenue growth trajectory is uncertain, with no disclosed revenue history beyond the latest financial snapshot. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the negative net cash position after subtracting total debt raises concerns about the company's ability to meet short-term obligations. The company's capital structure is heavily leveraged, with long-term debt of 15,790,870 CAD, which could limit its financial flexibility. The company's risk assessment highlights a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt is a key flag, indicating potential challenges in maintaining liquidity. The company's capital structure is heavily leveraged, with long-term debt of 15,790,870 CAD, which could limit its financial flexibility. The company's free cash flow is negative, and its operating cash flow is insufficient to cover capital expenditures, suggesting a need for external financing. Recent events and filings for Greenway Greenhouse Cannabis Corp are not disclosed in the available data. The company's financial performance and risk profile suggest that it may need to secure additional financing to support its operations and capital expenditures. The company's reliance on debt financing and its negative net income raise concerns about its long-term financial stability.

30-day price · GWAY.CD+0.00 (+0.0%)
Low$0.14High$0.18Close$0.18As of17 May, 00:00 UTC
Profile
CompanyGreenway Greenhouse Cannabis Corp
TickerGWAY.CD
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Greenway Greenhouse Cannabis Corp is a Canada-based federally licensed cannabis cultivator that supplies bulk packaged cannabis to the Canadian cannabis industry through its nursery, cultivation, and retail operations.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.

Greenway Greenhouse Cannabis Corp has a debt-to-equity ratio of 1.57, indicating a moderate reliance on debt financing, and a current ratio of 0.49, suggesting potential liquidity constraints in the short term. The company's free cash flow is negative at -320,350 CAD, and its operating cash flow is 1,806,460 CAD, highlighting a mismatch between cash inflows and outflows. The return on equity is -20.47%, and the return on assets is -6.38%, both significantly below the industry median for profitability metrics. The company's operating income is -958,940 CAD, and its net income is -2,057,450 CAD, indicating a loss-making position. These figures are well below the industry median for operating and net margins, suggesting that Greenway Greenhouse Cannabis Corp is underperforming in terms of profitability. The company's capital expenditure of -194,370 CAD reflects ongoing investment in its operations, but the negative net income raises concerns about the sustainability of these investments. Greenway Greenhouse Cannabis Corp operates in three segments: Greenway Nursery, Greenway Cultivation, and Greenway Farmgate Retail Store. The company's revenue is concentrated in these segments, with no disclosed geographic diversification. The lack of geographic diversification increases the company's exposure to regional market risks. The company's revenue concentration in a single country (Canada) and within a narrow set of segments suggests a high level of business risk. The company's revenue growth trajectory is uncertain, with no disclosed revenue history beyond the latest financial snapshot. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the negative net cash position after subtracting total debt raises concerns about the company's ability to meet short-term obligations. The company's capital structure is heavily leveraged, with long-term debt of 15,790,870 CAD, which could limit its financial flexibility. The company's risk assessment highlights a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt is a key flag, indicating potential challenges in maintaining liquidity. The company's capital structure is heavily leveraged, with long-term debt of 15,790,870 CAD, which could limit its financial flexibility. The company's free cash flow is negative, and its operating cash flow is insufficient to cover capital expenditures, suggesting a need for external financing. Recent events and filings for Greenway Greenhouse Cannabis Corp are not disclosed in the available data. The company's financial performance and risk profile suggest that it may need to secure additional financing to support its operations and capital expenditures. The company's reliance on debt financing and its negative net income raise concerns about its long-term financial stability.
Key takeaways
  • Greenway Greenhouse Cannabis Corp is a loss-making cannabis cultivator with a negative net income of -2,057,450 CAD.
  • The company has a high debt-to-equity ratio of 1.57 and a current ratio of 0.49, indicating liquidity and solvency risks.
  • The company's return on equity is -20.47%, and its return on assets is -6.38%, both significantly below industry medians.
  • Greenway Greenhouse Cannabis Corp operates in three segments with no geographic diversification, increasing its exposure to regional market risks.
  • The company's free cash flow is negative, and its operating cash flow is insufficient to cover capital expenditures, suggesting a need for external financing.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCAD
Revenue$8.9M
Gross profit$1.6M
Operating income-$958.9k
Net income-$2.1M
R&D
SG&A
D&A
SBC
Operating cash flow$1.8M
CapEx-$194.4k
Free cash flow-$320.4k
Total assets$32.3M
Total liabilities$22.2M
Total equity$10.1M
Cash & equivalents
Long-term debt$15.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$10.1M
Net cash-$15.8M
Current ratio0.5
Debt/Equity1.6
ROA-6.4%
ROE-20.5%
Cash conversion-88.0%
CapEx/Revenue-2.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Pharmaceuticals · cohort 25 companies
MetricGWAY.CDActivity
Op margin-10.7%18.2% medp25 18.2% · p75 24.6%bottom quartile
Net margin-23.0%14.7% medp25 11.7% · p75 28.1%bottom quartile
Gross margin17.9%19.7% medp25 19.7% · p75 39.8%bottom quartile
R&D / revenue24.3% medp25 6.6% · p75 24.3%
CapEx / revenue-2.2%4.9% medp25 4.2% · p75 6.3%bottom quartile
Debt / equity157.0%71.3% medp25 19.0% · p75 91.7%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 20:20 UTC#284c5553
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 20:22 UTCJob: d9e4326e